SuperworthWave Life Sciences shares outstanding WVE
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 204M
- On a year earlier
- +24.4%
- more shares
Wave Life Sciences had 204M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 24.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 180.2M | +12% |
| FY2024 | 161.5M | +46% |
| FY2023 | 110.8M | +18% |
| FY2022 | 94M | +64% |
| FY2021 | 57.2M | +17% |
| FY2020 | 48.8M | +42% |
| FY2019 | 34.3M | +16% |
| FY2018 | 29.5M | +6% |
| FY2017 | 27.8M | +18% |
| FY2016 | 23.5M | +54% |
| FY2015 | 15.3M | +258% |
| FY2014 | 4.3M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 204M | +24% | |
| Q1 FY26 | 200.2M | +23% | |
| Q4 FY25 | 180.2M | +12% | |
| Q3 FY25 | 167.7M | +27% | |
| Q2 FY25 | 164M | +27% | |
| Q1 FY25 | 162.6M | +26% | |
| Q4 FY24 | 161.5M | +46% | |
| Q3 FY24 | 132.6M | +24% | |
| Q2 FY24 | 129.5M | +23% | |
| Q1 FY24 | 129.3M | +27% | |
| Q4 FY23 | 110.8M | +18% | |
| Q3 FY23 | 107M | +14% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Wave Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.